{"transactions":[{"id":750070,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:13:09.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":false,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001062822-26-000106","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000106/form4.xml","form_type":"4"}},{"id":750069,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-04T20:13:09.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":293177,"source":{"system":"sec-edgar","filing":"0001062822-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000106/form4.xml","form_type":"4"}},{"id":794413,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:57:03.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":43478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":43478,"derivative":{"exercise_price":1.61,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":43478},"source":{"system":"sec-edgar","filing":"0001062822-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000090/form4.xml","form_type":"4"}},{"id":794412,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-05-04T20:57:03.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":35714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":35714,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35714},"source":{"system":"sec-edgar","filing":"0001062822-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000090/form4.xml","form_type":"4"}},{"id":1125934,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-03T20:23:33.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":89312,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001127602-25-016473","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016473/form4.xml","form_type":"4"}},{"id":1125933,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T20:23:33.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":103806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":103806,"derivative":{"exercise_price":0.6216,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":103806},"source":{"system":"sec-edgar","filing":"0001127602-25-016473","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016473/form4.xml","form_type":"4"}},{"id":1151236,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-13T21:50:50.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-25-014144","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014144/form4.xml","form_type":"4"}},{"id":1151235,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-13T21:50:50.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":203865,"source":{"system":"sec-edgar","filing":"0001127602-25-014144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014144/form4.xml","form_type":"4"}},{"id":1519510,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-13T20:03:48.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":36810,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-24-015082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015082/form4.xml","form_type":"4"}},{"id":1519509,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:03:48.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":44906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":44906,"derivative":{"exercise_price":1.79,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":44906},"source":{"system":"sec-edgar","filing":"0001127602-24-015082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015082/form4.xml","form_type":"4"}},{"id":1534033,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-04-29T20:20:43.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":false,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-24-013557","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013557/form4.xml","form_type":"4"}},{"id":1534032,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-29T20:20:43.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":167055,"source":{"system":"sec-edgar","filing":"0001127602-24-013557","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013557/form4.xml","form_type":"4"}},{"id":1874019,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2023-05-31T20:12:47.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":2053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2053},"source":{"system":"sec-edgar","filing":"0001209191-23-033104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123033104/doc4.xml","form_type":"4"}},{"id":1874018,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T20:12:47.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":2053,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."}],"balance_after":109954,"source":{"system":"sec-edgar","filing":"0001209191-23-033104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123033104/doc4.xml","form_type":"4"}},{"id":1874017,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T20:12:47.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":1353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":107901,"source":{"system":"sec-edgar","filing":"0001209191-23-033104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123033104/doc4.xml","form_type":"4"}},{"id":1883124,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-22T20:06:47.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":false,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-23-016437","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016437/form4.xml","form_type":"4"}},{"id":1883123,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-22T20:06:47.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":159023,"source":{"system":"sec-edgar","filing":"0001127602-23-016437","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016437/form4.xml","form_type":"4"}},{"id":1911583,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T20:29:13.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":12658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":12658,"derivative":{"exercise_price":2.36,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":12658},"source":{"system":"sec-edgar","filing":"0001127602-23-013788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013788/form4.xml","form_type":"4"}},{"id":1911582,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-28T20:29:13.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":8032,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-23-013788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013788/form4.xml","form_type":"4"}},{"id":1926145,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Unit","published_at":"2023-04-05T20:09:07.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":2053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the earlier of (i) August 15, 2028 (at which time, such shares of Common Stock will be subject to transfer restrictions) and (ii) the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the earlier of (i) August 15, 2028 (at which time, such shares of Common Stock will be subject to transfer restrictions) and (ii) the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors."}],"balance_after":2053,"derivative":{"underlying":"Common Stock","underlying_shares":2053},"source":{"system":"sec-edgar","filing":"0001209191-23-023291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123023291/doc4.xml","form_type":"4"}},{"id":2071198,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:32:14.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":5067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":106548,"source":{"system":"sec-edgar","filing":"0001209191-23-000960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919123000960/doc4.xml","form_type":"4"}},{"id":2109617,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T21:12:15.000Z","date":"2022-11-17","kind":"purchase","acquired":true,"shares":30000,"price":4.1708,"value":125124.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.0554 to $4.2084, inclusive. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":101481,"source":{"system":"sec-edgar","filing":"0001209191-22-058099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122058099/doc4.xml","form_type":"4"}},{"id":2143242,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T21:36:20.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":4595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":71481,"source":{"system":"sec-edgar","filing":"0001209191-22-052843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122052843/doc4.xml","form_type":"4"}},{"id":2213474,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T20:40:29.000Z","date":"2022-07-04","kind":"grant","acquired":true,"shares":2745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":66886,"source":{"system":"sec-edgar","filing":"0001209191-22-041165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122041165/doc4.xml","form_type":"4"}},{"id":2260534,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-23T20:17:50.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":9302,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-22-015376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015376/form4.xml","form_type":"4"}},{"id":2260533,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T20:17:50.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":14402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":14402,"derivative":{"exercise_price":1.77,"expiration_date":"2032-05-21","underlying":"Common Stock","underlying_shares":14402},"source":{"system":"sec-edgar","filing":"0001127602-22-015376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015376/form4.xml","form_type":"4"}},{"id":2286824,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-02T20:18:32.000Z","date":"2022-04-30","kind":"exercise","acquired":false,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-22-012833","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012833/form4.xml","form_type":"4"}},{"id":2286823,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-02T20:18:32.000Z","date":"2022-04-30","kind":"exercise","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":149721,"source":{"system":"sec-edgar","filing":"0001127602-22-012833","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012833/form4.xml","form_type":"4"}},{"id":2303058,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:19:53.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":1797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":64141,"source":{"system":"sec-edgar","filing":"0001209191-22-023472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122023472/doc4.xml","form_type":"4"}},{"id":2439228,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-01-10T21:17:55.000Z","date":"2021-07-01","kind":"gift","acquired":false,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":145697,"source":{"system":"sec-edgar","filing":"0001127602-22-001242","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222001242/form5.xml","form_type":"5"}},{"id":2446374,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:55.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":1179,"price":15.9,"value":18746.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":62344,"source":{"system":"sec-edgar","filing":"0001209191-22-001665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919122001665/doc4.xml","form_type":"4"}},{"id":2547654,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-06T20:18:03.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":998,"price":18.78,"value":18742.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":61165,"source":{"system":"sec-edgar","filing":"0001209191-21-059828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919121059828/doc4.xml","form_type":"4"}},{"id":2640197,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T20:31:20.000Z","date":"2021-07-05","kind":"grant","acquired":true,"shares":523,"price":35.84,"value":18744.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":60167,"source":{"system":"sec-edgar","filing":"0001209191-21-045811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919121045811/doc4.xml","form_type":"4"}},{"id":2733369,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T21:07:56.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6475,"derivative":{"exercise_price":5.04,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001127602-21-014973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014973/form4.xml","form_type":"4"}},{"id":2733368,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-03T21:07:56.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":4024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-21-014973","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014973/form4.xml","form_type":"4"}},{"id":2738796,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-27T20:50:42.000Z","date":"2021-04-24","kind":"exercise","acquired":false,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-21-014523","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014523/form4.xml","form_type":"4"}},{"id":2738795,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-27T20:50:42.000Z","date":"2021-04-24","kind":"exercise","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":151397,"source":{"system":"sec-edgar","filing":"0001127602-21-014523","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014523/form4.xml","form_type":"4"}},{"id":2755028,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-07T20:36:20.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":609,"price":30.77,"value":18738.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":59644,"source":{"system":"sec-edgar","filing":"0001209191-21-025887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919121025887/doc4.xml","form_type":"4"}},{"id":2917875,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T21:29:48.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":59035,"source":{"system":"sec-edgar","filing":"0001209191-21-002091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919121002091/doc4.xml","form_type":"4"}},{"id":3020399,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-30T22:05:04.000Z","date":"2020-09-28","kind":"grant","acquired":true,"shares":996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":58311,"source":{"system":"sec-edgar","filing":"0001209191-20-052501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919120052501/doc4.xml","form_type":"4"}},{"id":3095980,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T20:22:27.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":57315,"source":{"system":"sec-edgar","filing":"0001209191-20-039745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919120039745/doc4.xml","form_type":"4"}},{"id":3169366,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:48:56.000Z","date":"2020-04-26","kind":"exercise","acquired":false,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-20-014570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014570/form4.xml","form_type":"4"}},{"id":3169365,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:48:56.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":10638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-20-014570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014570/form4.xml","form_type":"4"}},{"id":3169364,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T20:48:56.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":18115,"derivative":{"exercise_price":1.86,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001127602-20-014570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014570/form4.xml","form_type":"4"}},{"id":3169363,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-27T20:48:56.000Z","date":"2020-04-26","kind":"exercise","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":140759,"source":{"system":"sec-edgar","filing":"0001127602-20-014570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014570/form4.xml","form_type":"4"}},{"id":3190121,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-01T20:25:20.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":1128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":56575,"source":{"system":"sec-edgar","filing":"0001209191-20-022113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919120022113/doc4.xml","form_type":"4"}},{"id":3328343,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:14:12.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":55447,"source":{"system":"sec-edgar","filing":"0001209191-20-000267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919120000267/doc4.xml","form_type":"4"}},{"id":3402151,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T21:03:26.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":54978,"source":{"system":"sec-edgar","filing":"0001209191-19-051819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919119051819/doc4.xml","form_type":"4"}},{"id":3412793,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":1478,"price":2.73,"value":4034.94,"ownership":{"direct":true},"balance_after":137293,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412792,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":3700,"price":2.75,"value":10175.0,"ownership":{"direct":true},"balance_after":135815,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412791,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":791,"price":2.6,"value":2056.6,"ownership":{"direct":true},"balance_after":132115,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412790,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":200,"price":2.59,"value":518.0,"ownership":{"direct":true},"balance_after":131324,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412789,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":900,"price":2.57,"value":2313.0,"ownership":{"direct":true},"balance_after":131124,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412788,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":100,"price":2.58,"value":258.0,"ownership":{"direct":true},"balance_after":130224,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412787,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":900,"price":2.56,"value":2304.0,"ownership":{"direct":true},"balance_after":130124,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412786,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":800,"price":2.54,"value":2032.0,"ownership":{"direct":true},"balance_after":129224,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412785,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":400,"price":2.55,"value":1020.0,"ownership":{"direct":true},"balance_after":128424,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412784,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":820,"price":2.53,"value":2074.6,"ownership":{"direct":true},"balance_after":128024,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412783,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":1405,"price":2.52,"value":3540.6,"ownership":{"direct":true},"balance_after":127204,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412782,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":100,"price":2.525,"value":252.5,"ownership":{"direct":true},"balance_after":125799,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412781,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":100,"price":2.535,"value":253.5,"ownership":{"direct":true},"balance_after":125699,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412780,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":1151,"price":2.5,"value":2877.5,"ownership":{"direct":true},"balance_after":125599,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412779,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":3300,"price":2.48,"value":8184.0,"ownership":{"direct":true},"balance_after":124448,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412778,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":2500,"price":2.47,"value":6175.0,"ownership":{"direct":true},"balance_after":121148,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412777,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":200,"price":2.45,"value":490.0,"ownership":{"direct":true},"balance_after":118648,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412776,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":1400,"price":2.46,"value":3444.0,"ownership":{"direct":true},"balance_after":118448,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412775,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":1784,"price":2.49,"value":4442.16,"ownership":{"direct":true},"balance_after":117048,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412774,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":100,"price":2.485,"value":248.5,"ownership":{"direct":true},"balance_after":115264,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412773,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":776,"price":2.51,"value":1947.76,"ownership":{"direct":true},"balance_after":115164,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412772,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":295,"price":2.515,"value":741.925,"ownership":{"direct":true},"balance_after":114388,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412771,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":500,"price":2.43,"value":1215.0,"ownership":{"direct":true},"balance_after":114093,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412770,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":300,"price":2.41,"value":723.0,"ownership":{"direct":true},"balance_after":113593,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412769,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":800,"price":2.4,"value":1920.0,"ownership":{"direct":true},"balance_after":113293,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412768,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:27:35.000Z","date":"2019-09-16","kind":"purchase","acquired":true,"shares":200,"price":2.38,"value":476.0,"ownership":{"direct":true},"balance_after":112493,"source":{"system":"sec-edgar","filing":"0001127602-19-028593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028593/form4.xml","form_type":"4"}},{"id":3412738,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":300,"price":2.48,"value":744.0,"ownership":{"direct":true},"balance_after":112293,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412737,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":100,"price":2.4775,"value":247.75,"ownership":{"direct":true},"balance_after":111993,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412736,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":3336,"price":2.47,"value":8239.92,"ownership":{"direct":true},"balance_after":111893,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412735,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":100,"price":2.465,"value":246.5,"ownership":{"direct":true},"balance_after":108557,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412734,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":5200,"price":2.46,"value":12792.0,"ownership":{"direct":true},"balance_after":108457,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412733,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":2400,"price":2.45,"value":5880.0,"ownership":{"direct":true},"balance_after":103257,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412732,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":15158,"price":2.44,"value":36985.52,"ownership":{"direct":true},"balance_after":100857,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412731,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":400,"price":2.435,"value":974.0,"ownership":{"direct":true},"balance_after":85699,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412730,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":5225,"price":2.43,"value":12696.75,"ownership":{"direct":true},"balance_after":85299,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412729,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":9943,"price":2.42,"value":24062.06,"ownership":{"direct":true},"balance_after":80074,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412728,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":1000,"price":2.415,"value":2415.0,"ownership":{"direct":true},"balance_after":70131,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412727,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":8112,"price":2.41,"value":19549.92,"ownership":{"direct":true},"balance_after":69131,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412726,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":200,"price":2.405,"value":481.0,"ownership":{"direct":true},"balance_after":61019,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412725,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":9450,"price":2.4,"value":22680.0,"ownership":{"direct":true},"balance_after":60819,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412724,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":14338,"price":2.39,"value":34267.82,"ownership":{"direct":true},"balance_after":51369,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412723,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":1396,"price":2.385,"value":3329.46,"ownership":{"direct":true},"balance_after":37031,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412722,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":9784,"price":2.38,"value":23285.92,"ownership":{"direct":true},"balance_after":35635,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412721,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":2206,"price":2.37,"value":5228.22,"ownership":{"direct":true},"balance_after":25851,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412720,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":1200,"price":2.36,"value":2832.0,"ownership":{"direct":true},"balance_after":23645,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412719,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":600,"price":2.35,"value":1410.0,"ownership":{"direct":true},"balance_after":22445,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412718,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":3500,"price":2.34,"value":8190.0,"ownership":{"direct":true},"balance_after":21845,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412717,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":1000,"price":2.33,"value":2330.0,"ownership":{"direct":true},"balance_after":18345,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412716,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":1000,"price":2.32,"value":2320.0,"ownership":{"direct":true},"balance_after":17345,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412715,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":1600,"price":2.31,"value":3696.0,"ownership":{"direct":true},"balance_after":16345,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412714,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":400,"price":2.3,"value":920.0,"ownership":{"direct":true},"balance_after":14745,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}},{"id":3412713,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41453,"kind":"person","name":"SOBECKI CHRISTOPHER J","position":1,"cik":"0001053892","reported_name":"SOBECKI CHRISTOPHER J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-17T21:23:43.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":500,"price":2.28,"value":1140.0,"ownership":{"direct":true},"balance_after":14345,"source":{"system":"sec-edgar","filing":"0001127602-19-028591","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219028591/form4.xml","form_type":"4"}}],"next_cursor":"2019-09-17T21:23:43.000000Z,3412713"}